Ali Saleh Alyami1,2,3, Hannah Grace Williams2, Konstantinos Argyriou4, Penny Gowland2,4, Gordon W. Moran1,4, and Caroline Hoad 2,4
1Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, United Kingdom, 2Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom, 3Faculty of Applied Medical Sciences, Diagnostic Radiology, Jazan University, Jazan, Saudi Arabia, 4NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals NHS Trust and University of Nottingham, University of Nottingham, Nottingham, United Kingdom
Synopsis
Quantitative MRI datasets based on relaxometry
and Magnetisation Transfer (MT) sequences could be used as potential biomarkers
of disease activity in Inflammatory Bowel Disease. The aim of the study was to
measure the repeatability of T2, T1 and MT small bowel measurements following
bowel preparation and administration of an anti-spasmodic agent. Inter-observer
variations in these measurements were also assessed. The quantitative MRI
methods examined showed excellent repeatability for T2 and good repeatability
for T1 parameters for both repeatability between visits and reproducibility of
results between observers from data of a small group of healthy subjects.
Introduction
T2- and T1-weighted sequences are used as disease activity biomarkers in
inflammatory Crohn’s disease (CD)(1), with T2-w images showing
inflammation as a hyper-intense signal. Magnetization transfer (MT) imaging may
have a role in the imaging of fibrosis in CD (2). Quantitative
analyses of MRI sequences are increasingly being used for the evaluation of different
disease such as
CD and liver cirrhosis (3,4) as they
provide greater sensitivity to change. T2 and T1 can be measured in the abdomen
using spin-echo-prepared (5) or Inversion recovery-prepared sequences
(6) with a fast imaging readout and varying the echo time (TE) or
inversion time (TI). Evaluating the
repeatability of these types of sequence in the bowel is important before
embarking on disease-specific outcomes studies. The aim of the study was to
measure the repeatability of T2, T1 and MT small bowel wall measurements
following bowel preparation and administration of an anti-spasmodic agent in
healthy volunteers and assess inter-observer variability of these measurements.Methods
Ten healthy volunteers were recruited and scanned twice with a minimum two
weeks interval between visits 1 and 2, using a 3T Ingenia (Philips, Best, The
Netherlands).
Forty minutes before scanning, volunteers were given 1000 mL of bowel preparation
(2.5% mannitol with 0.2 % locust bean gum), to ingest slowly before scanning. After
initial planning scans, and prior to these quantitative acquisitions, subjects were
given two doses of an anti-spasmodic agent (hyoscine butylbromide 20 mg) intravenously
to immobilise the small bowel. One dose was
administered before the T2 measurements and the second dose before the T1 and
MT scans.
Imaging was performed in a feet-first prone position. The MRI sequence parameters
for T1, T2 and MT sequences are presented in table 1.
All data were motion
corrected prior to the wall identification. Regions of interest (ROI) were
defined using custom-written software in MATLAB (R2017a, Mathworks) to identify
the bowel wall. For T2, the software used
a combination of edge detection and thresholding to identify the walls semi-automatically
(7). For T1 and MT, the observer drew ROIs on the images to identify small
segments of wall. An MT ratio (MTR) image
was calculated voxel by voxel after motion correction but prior to the
definition of the wall ROIs. The data from the ROIs were then fitted to a model
of the signal evolution to calculate the T2 of the ROI taking into account the
T2 of the content and partial volume effects. For T1, regions in the small
bowel content were fitted for T1 first, and an average of these values used in
the T1 fit for the wall, again to allow for partial volume effects in the
ROI. Multiple ROIs of bowel wall were
drawn on each data set and a median (interquartile
range) of
the data was then calculated for each subject per visit. The repeatability of
these measurements were determined from the intra-class correlation coefficient
(ICC) between visits.
The data were analysed
separately by 2 observers to provide information on the inter-observer
variation and the ICC calculated.Results
All participants (9 female, 1 male:
mean age 30± 8 yrs) completed both scans. Figure 1
and 2 show example images for T1 and T2 data. Some data could not be used in
the analysis due to motion of the bowel loops during the acquisition. Figure
3 shows the T2, T1 and MTR median data for each subject at both visits. One
subject appeared to have a longer T2 than the rest of the cohort, however this
was repeatable over the 2 visits and between the observers for one of the
visits. However, an excellent ICC =0.945 was calculated for T2 across visits
(p=0.001, N=8), while the T1 data had a good repeatability ICC=0.653, (P=0.05,
N=9) the MTR data repeatability had a low ICC=-0.452, (P=0.69, N= 9).
Figure 4 shows the
inter-observer data. One outlier in the
T2 data was observed who had large differences in T2 values, despite this, an
excellent correlation (ICC =0.943) between both observers was found for T2 (p
value <0.001, N=17). A good correlation was calculated for T1 (ICC =0.716,
p=0.006, N=16), and a low ICC was calculated for MTR (0.204, p=0.198, N=18). Discussion
The paired
acquisitions from visit 1 and 2 were well matched within the subjects over the two
weeks scan interval for T2 and T1. The inter-observer measurements and scan
reproducibility of the T2 measurements was excellent with a strong ICC. The T1 data
showed moderate correlation, whilst the MTR data did not correlate well. This may be due to two reasons. The MTR data could not take into account any
partial volume effects of the contents in the wall ROIs which may introduce
additional errors. Also, the variation
of this parameter across the subjects was small with all data within a 0.08
range. Diseased tissue may have considerably different MTR and hence this range
of variation may be sufficient for this parameter to also be useful. In conclusion, T2 and T1 of the small bowel
are reproducible measurements which may prove to be accurate imaging biomarkers
in Inflammatory bowel disease.Acknowledgements
This work was funded by Jazan University,
Saudi ArabiaReferences
1. Church, P.C., et al., Systematic
review with meta-analysis: magnetic resonance enterography signs for the
detection of inflammation and intestinal damage in Crohn's disease. Aliment
Pharmacol Ther, 2015. 41(2): p. 153-66.
2. Li X-h, Mao R, Huang S-y, Sun C-h, Cao Q-h, Fang
Z-n, et al. Characterization of degree of intestinal fibrosis in patients with
Crohn disease by using magnetization transfer MR imaging. Radiology.
2018;287(2):494-503.
3. Li Y, Hauenstein K. New imaging
techniques in the diagnosis of inflammatory bowel diseases. Visceral Medicine.
2015;31(4):227-34.
4. Lee Y, Lee SS, Kim N, Kim E, Kim YJ, Yun S-C, et al.
Intravoxel incoherent motion diffusion-weighted MR imaging of the liver: effect
of triggering methods on regional variability and measurement repeatability of
quantitative parameters. Radiology. 2014; 274 (2):405-15.
5. Hoad CL, Cox EF, Gowland PA. Quantification of T2 in
the abdomen at 3.0 T using a T2‐prepared balanced turbo field echo sequence.
Magnetic Resonance in Medicine: 2010;63(2):356-64.
6. Hoad et al. Abstract 1275 Proc Intl Soc Mag Reson
Med 20. 2012.
7. H. Williams et al. Proc ISMRM 2018 p4718